According to IMARC Group latest published report, the global nanorobotics market reached a value of US$ 5.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2027, exhibiting a CAGR of 11.75% during 2022-2027.
Nanorobotics is an emerging technology that helps in creating machines or robots, including components around the scale of a nanometer. These robots are widely known as nanorobots that can be injected into patients to perform diagnosis and provide treatment at the cellular level. Nanorobots can also be used in pharmacokinetics, targeting drug delivery in cancer therapeutics, disease monitoring, improving the effectiveness and efficiency of healthcare, etc.
Get a PDF Sample for more detailed market insights:https://www.imarcgroup.com/nanorobotics-market/requestsample
Market Trends and Drivers:
Extensive applications of nanorobotics in the medical industry are primarily driving the market growth. Nanorobots can also serve as antibodies or antiviral agents in patients with compromised immunity or diseases that do not react to traditional treatment methods. As a result, nanorobots are widely used in gene therapy and cancer treatment. They are also deployed in various dentistry procedures and act as ancillary devices for processing different chemical reactions in the affected organs.
Furthermore, nanorobots are utilized for monitoring and controlling glucose levels along with repairing damaged tissues and unblocking arteries affected by plaques. In the coming years, the increasing investments in the development of technologically-advanced molecular robotics are further expected to drive the global market for nanorobotics.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Bruker Corporation, EV Group GmbH, Ginkgo Bioworks, Imina Technologies SA, JEOL Ltd., Kleindiek Nanotechnik GmbH, Nanonics Imaging Limited, Oxford Instruments plc, Synthace Limited, Thermo Fisher Scientific Inc., Toronto Nano Instrumentation Inc and Zymergen Inc.
Ask An Analyst:- https://www.imarcgroup.com/request?type=report&id=3168&flag=C
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Related Reports By IMARC Group
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St. Brooklyn, NY 11249,
Follow us on twitter: @imarcglobal